Skip to main content
. 2017 Jul 31;7:6885. doi: 10.1038/s41598-017-06969-4

Figure 3.

Figure 3

Hesperidin treatment preserved RGC marker-positive cells after NMDA injury. Representative photographs at lower (ac) and higher (dl) magnification with nuclear staining (DAPI) and immunostaining with anti-RBPMS antibody, taken 24 h after intravitreal injection with PBS (a,d,g,j), 30 nmol NMDA (b,e,h,k), or NMDA with hesperidin (c,f,i,l). RBPMS-positive cells in the GCL are shown by the arrows. (m) Histogram showing the average number of RBPMS-positive cells in the retinas. Data represent mean ± SD, (vehicle, n = 6, NMDA, n = 8, NMDA with hesperidin, n = 7) ***p < 0.001. A-C scale bar: 500 µm, D-L scale bar: 50 µm. GCL; ganglion cell layer, INL; inner nuclear layer, ONL; outer nuclear layer.